Clinical Trial Update: Endurant CHevAr New Indication Trial: ENCHANT

View source ↗

Summary

Medtronic's Endurant CHevAr is being studied for a new indication in abdominal aortic aneurysm (ENCHANT); the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm

Drugs mentioned

• Endurant CHevAr

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: AAA - Abdominal Aortic Aneurysm | Status: ACTIVE_NOT_RECRUITING